Tetraspanin-enriched microdomains and endothelial barrier function
Tetraspanin-enriched microdomains and endothelial barrier function
批准号:
9238927
负责人:
XIN A ZHANG
金额:
$37.44万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-12-15 至 2020-11-30
关键词:
1-Phosphatidylinositol 4-KinaseActinsAdhesionsAdhesivenessAnimal ModelBasal CellBasement membraneBlood VesselsC-terminalCardiovascular DiseasesCell AdhesionCell Adhesion MoleculesCell CommunicationCell membraneCell physiologyCell surfaceCell-Cell AdhesionCell-Matrix JunctionCellsCyclic AMPCysteineCytoplasmic TailCytoskeletonCytosolDepositionDevelopmentDiseaseEndothelial CellsEndotheliumEquilibriumExtravasationFilopodiaFosteringGenerationsGoalsGray unit of radiation doseGrowth Factor ReceptorsGuanosine Triphosphate PhosphohydrolasesHumanIn VitroInfectionInflammationIntegrin BindingIntegrinsIntracellular Signaling ProteinsKnockout MiceLamininLeadLinkMembraneMembrane MicrodomainsMolecularMonomeric GTP-Binding ProteinsMusPathogenesisPathologyPermeabilityPlayPreventionProteinsRoleSignal TransductionSignaling ProteinSorting - Cell MovementStress FibersStructureSurfaceTransmembrane DomainVascular DiseasesVascular Permeabilitiesbasebiophysical propertiescell motilitydisulfide bondextracellularin vivoinsightmembernanoscalenovelpreventreceptorrhotherapeutic developmentvascular abnormality
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Cell-cell and cell-matrix adhesions play essential roles in endothelial barrier function. Various
tetraspanins are expressed in endothelium, form tetraspanin-enriched microdomains with cell
adhesion proteins such as integrins, and regulate endothelial cell adhesion and vascular
permeability. Our early study revealed that tetraspanins are required for maintaining proper
endothelial adhesiveness, endothelial barrier, and vascular permeability. We have demonstrated
that, to sustain vascular stability, tetraspanin-enriched microdomains tune the balance of Rac1
and RhoA small GTPase activities or the balance of cortical actin meshwork and stress fibers to
sustain endothelial cell-cell and cell matrix adhesions. But the in-depth mechanisms by which
tetraspanins regulate endothelial barrier function still remain elusive.
We will use tetraspanin CD151 as example in this study to elucidate the mechanisms by which
tetraspanin-enriched microdomains regulate endothelial barrier function and vascular permeability.
The overarching hypotheses of this project include that, at the cellular level, CD151 promotes
endothelial barrier function by primarily increasing endothelial cell-matrix interactions, which
subsequently elevates endothelial cell-cell adhesion. Meanwhile, CD151 can also directly
reinforce endothelial cell-cell interaction. At the molecular level, CD151 reinforces cell adhesions
by enhancing the functional accessibility and nanoscale organization of cell adhesion proteins at
endothelial cell surface.
Specifically, we will first unravel the mechanism by which CD151 reinforces endothelial cell-
matrix adhesion. We will assess both in vitro and in vivo mechanistic roles of CD151 in integrin
activation and accessibility at the basal surface of endothelial cells. Secondly, we will reveal the
mechanism by which CD151 reinforces endothelial cell-cell adhesion. We will assess both in vitro
and in vivo mechanistic roles of CD151 in maintaining structural and functional integrity of
endothelial cell-cell contacts, which directly prevents endothelial hyper-permeability. Finally, we
will delineate the signaling mechanisms by which CD151 reinforces endothelial barrier and
reduces vascular hyper-permeability.
Hence, the general goal of this project is to understand how CD151 sustains the endothelium
barrier function by assessing both in vitro and in vivo mechanistic roles of CD151 in stabilizing the
structural and functional interactions of endothelium with the underlying basement membrane and
in maintaining the structural and functional integrity of endothelial cell-cell contacts and junctions.
From these studies, we will understand why and how tetraspanin-enriched microdomains are
important for endothelial barrier function, establish a novel paradigm between vascular
permeability and membrane organization of cell adhesion molecules, and delineate the signaling
axis that governs the fine balance of small GTPases in endothelium. From the in-depth
mechanistic study, we will develop an integrated understanding of the unique features of
tetraspanin-enriched microdomains, which will ultimately lead to the development of therapeutic
mean against vascular diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
How Tetraspanins Regulate Sepsis
-
批准号:10052714
-
项目类别:
-
资助金额:$29.0万
-
财政年份:2020
-
负责人:XIN A ZHANG
-
依托单位:
How Tetraspanins Regulate Sepsis
-
批准号:10654676
-
项目类别:
-
资助金额:$29.0万
-
财政年份:2020
-
负责人:XIN A ZHANG
-
依托单位:
How Tetraspanins Regulate Sepsis
-
批准号:10437734
-
项目类别:
-
资助金额:$29.0万
-
财政年份:2020
-
负责人:XIN A ZHANG
-
依托单位:
How Tetraspanins Regulate Sepsis
-
批准号:10624508
-
项目类别:
-
资助金额:$29.0万
-
财政年份:2020
-
负责人:XIN A ZHANG
-
依托单位:
Diversity Supplement of R01 grant "How Tetraspanins Regulate Vascular Morphogenesis"
-
批准号:9796052
-
项目类别:
-
资助金额:$3.79万
-
财政年份:2017
-
负责人:XIN A ZHANG
-
依托单位:
How Tetraspanins Regulate Vascular Morphogenesis
-
批准号:9765373
-
项目类别:
-
资助金额:$42.42万
-
财政年份:2017
-
负责人:XIN A ZHANG
-
依托单位:
How Tetraspanins Regulate Vascular Morphogenesis
-
批准号:9362663
-
项目类别:
-
资助金额:$37.0万
-
财政年份:2017
-
负责人:XIN A ZHANG
-
依托单位:
Molecular Mechanism of KAI1/CD82-mediated Suppression
-
批准号:6781299
-
项目类别:
-
资助金额:$22.01万
-
财政年份:2004
-
负责人:XIN A ZHANG
-
依托单位:
Molecular Mechanism of KAI1/CD82-mediated Suppression
-
批准号:7178435
-
项目类别:
-
资助金额:$21.8万
-
财政年份:2004
-
负责人:XIN A ZHANG
-
依托单位:
Molecular Mechanism of KAI1/CD82-mediated Suppression
-
批准号:7937533
-
项目类别:
-
资助金额:$4.64万
-
财政年份:2004
-
负责人:XIN A ZHANG
-
依托单位:
How KAI1/CD82 Suppresses Cancer Invasion and Metastasis
-
批准号:8707272
-
项目类别:
-
资助金额:$4.93万
-
财政年份:2004
-
负责人:XIN A ZHANG
-
依托单位:
How KAI1/CD82 Suppresses Cancer Invasion and Metastasis
-
批准号:8213635
-
项目类别:
-
资助金额:$27.98万
-
财政年份:2004
-
负责人:XIN A ZHANG
-
依托单位:
How KAI1/CD82 Suppresses Cancer Invasion and Metastasis
-
批准号:8052934
-
项目类别:
-
资助金额:$22.51万
-
财政年份:2004
-
负责人:XIN A ZHANG
-
依托单位:
Molecular Mmechanism of KAI1/CD82-mediated Suppression
-
批准号:7434152
-
项目类别:
-
资助金额:$3.91万
-
财政年份:2004
-
负责人:XIN A ZHANG
-
依托单位:
How KAI1/CD82 Suppresses Cancer Invasion and Metastasis
-
批准号:8459340
-
项目类别:
-
资助金额:$25.9万
-
财政年份:2004
-
负责人:XIN A ZHANG
-
依托单位:
How KAI1/CD82 Suppresses Cancer Invasion and Metastasis
-
批准号:8792665
-
项目类别:
-
资助金额:$3.92万
-
财政年份:2004
-
负责人:XIN A ZHANG
-
依托单位:
How KAI1/CD82 Suppresses Cancer Invasion and Metastasis
-
批准号:8396603
-
项目类别:
-
资助金额:$8.29万
-
财政年份:2004
-
负责人:XIN A ZHANG
-
依托单位:
How KAI1/CD82 Suppresses Cancer Invasion and Metastasis
-
批准号:8606820
-
项目类别:
-
资助金额:$21.84万
-
财政年份:2004
-
负责人:XIN A ZHANG
-
依托单位:
How KAI1/CD82 Suppresses Cancer Invasion and Metastasis
-
批准号:7891112
-
项目类别:
-
资助金额:$23.21万
-
财政年份:2004
-
负责人:XIN A ZHANG
-
依托单位:
How KAI1/CD82 Suppresses Cancer Invasion and Metastasis
-
批准号:8322915
-
项目类别:
-
资助金额:$4.59万
-
财政年份:2004
-
负责人:XIN A ZHANG
-
依托单位:
海外基金